Human leukemia cell binding and killing by anti-CD5 radioimmunotoxins
- 1 November 1987
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 13 (11) , 1701-1712
- https://doi.org/10.1016/0360-3016(87)90167-2
Abstract
No abstract availableThis publication has 58 references indexed in Scilit:
- Tumor cell binding and killing by CD5 radioimmunotoxinsInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Alterations in immune systemInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Radioimmunodetection of Cutaneous T-Cell Lymphoma with111In-Labeled T101 Monoclonal AntibodyNew England Journal of Medicine, 1986
- Selective tumor localization of radiolabeled anti-human melanoma monoclonal antibody fragment demonstrated in the nude mouse modelCancer, 1986
- Tumor location and drug targeting using a monoclonal antibody (anti‐SSEA‐1) and antigen‐binding fragmentsJournal of Surgical Oncology, 1986
- Comparison of the distribution and binding of monoclonal antibodies labeled with 131-iodine or 111-indiumEuropean Journal of Nuclear Medicine and Molecular Imaging, 1985
- The Human T-Cell ReceptorNew England Journal of Medicine, 1985
- Optimal elimination of leukemic T cells from human bone marrow with T101-ricin A-chain immunotoxinBlood, 1985
- Radiolabeling of monoclonal antibody against carcinoembryonic antigen with 88Y and biodistribution studiesInternational Journal of Nuclear Medicine and Biology, 1985
- [22] Iodine monochloride (ICI) iodination techniquesPublished by Elsevier ,1983